Current studies have shown that knockdown of Beclin-1 causes thyroid cancer cells to lose their epithelial properties and acquire mesenchymal characters consistent with EMT through stabilizing ZEB1 mRNA, and there is a negative correlation between Beclin-1 and ZEB1 in thyroid cancer [62]. This evidence concerns the gene BECN1 and thyroid cancer.